News

liver
Some patients who undergo selective internal radiotherapy (SIRT) with yttrium-90 (Y-90) may be eligible for liver resection, researchers reported. SIRT is typically a palliative procedure, but certain patients have a response that warrants surgical resection with curative intent. To better… Read More
bones
Researchers have identified factors that are linked with increased risk of symptomatic recurrence after radiofrequency ablation for osteoid osteomas. The retrospective cohort analysis took place at a single center and included 71 patients treated with CT-guided radiofrequency ablation from July… Read More
clipboard
The Society of Interventional Oncology (SIO) recently sent a letter to the National Comprehensive Cancer Network (NCCN) Kidney Cancer Guideline panel seeking changes to proposed guidelines for management of T1a renal masses. The NCCN guidelines are influential among both clinicians and payors, and… Read More
liver
AUSTIN, TX—Transarterial Y-90 radioembolization with resin microspheres using MIRD dosimetry for intrahepatic cholangiocarcinoma appears to be safe and shows promising survival outcomes, researchers from Beth Israel Deaconess Medical Center reported in an abstract presented at SIR. “There is this… Read More
lungs
AUSTIN, TX—Patients with metastatic neuroendocrine tumors may potentially be able to consider same-day mapping or no mapping prior to treatment with Y-90 radioembolization, based on the rare incidence of hepatopulmonary shunting in this population. Researchers presented their data in an abstract… Read More
liver
AUSTIN, TX—A systemic review and meta-analysis has found that an average tumor dose of 275 Gy for patients with hepatocellular carcinoma (HCC) treated with Y-90 radioembolization is able to predict objective tumor response. The authors undertook the review and analysis to better understand Y-90… Read More
liver
Liver resection may lead to better outcomes than transarterial chemoembolization (TACE) for cirrhotic patients with resectable intermediate-stage hepatocellular carcinoma (HCC), according to a study published in Cancer Medicine. Although TACE is typically recommended for intermediate-stage HCC,… Read More
liver
A combined microsphere sizing strategy seemed technically feasible and had a promising toxicity profile and effectiveness measures, researchers reported. The study was prospective, single-center, and had a single arm consisting of 36 consecutive patients with hepatocellular carcinoma (HCC) who had… Read More
kidneys
Cryoablation of clinical T1 renal tumors is linked with poorer oncologic outcomes than partial nephrectomy, but patients who underwent cryoablation had lower rates of complications and better preservation of renal function, according to a study published in the Journal of Cancer. “For patients… Read More
lungs
Patients who underwent stereotactic ablative radiotherapy (SABR) for medically inoperable early-stage non-small cell lung cancer (NSCLC) had a pathologic complete response (pCR) rate that was lower than expected, according to a study published in JAMA Oncology. The researchers undertook the study… Read More